Seeing Is Believing
with an average price target of $10717.89. This is a potential upside of $10716 (566984.13%) from yesterday's end of day stock price of $1.89.
Neurobo Pharmaceuticals's activity chart (see below) currently has 13 price targets and 13 ratings on display.
Analysts average stock forecasts to be materialized ratio is 52% with an average time for these price targets to be met of 96 days.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 31-Jan-2021. First documented stock forecast 29-Aug-2016.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$4800
4 years 8 months 16 days ago
(31-Jan-2021)
0/1 (0%)
$2520 (110.53%)
Hold
$12000
$11998.11 (634820.62%)
$108000
7 years 2 months 4 days ago
(12-Aug-2018)
3/5 (60%)
$2040 (20.48%)
130
Hold
$12000
$11998.11 (634820.62%)
7 years 2 months 7 days ago
(09-Aug-2018)
1/1 (100%)
$1200 (11.11%)
27
$12000
$11998.11 (634820.62%)
7 years 2 months 8 days ago
(08-Aug-2018)
1/2 (50%)
$-7620 (-38.84%)
1
Buy
8 years 27 days ago
(19-Sep-2017)
1/2 (50%)
$55440 (72.41%)
322
What is NRBO (Neurobo Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on NRBO (Neurobo Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on NRBO (Neurobo Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on NRBO (Neurobo Pharmaceuticals)?
Which analyst is the currently most bullish on NRBO (Neurobo Pharmaceuticals)?
Which analyst is the currently most reserved on NRBO (Neurobo Pharmaceuticals)?